These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21107432)

  • 1. Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
    Martinez-Martin FJ; Rodriguez-Rosas H; Peiro-Martinez I; Soriano-Perera P; Pedrianes-Martin P; Comi-Diaz C
    J Hum Hypertens; 2011 Jun; 25(6):346-53. PubMed ID: 21107432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
    Thomopoulos C; Tsioufis C; Makris T; Stefanadis C
    J Hum Hypertens; 2011 Jun; 25(6):401-2; author reply 403-4. PubMed ID: 21368776
    [No Abstract]   [Full Text] [Related]  

  • 3. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Drugs; 2011 Jan; 71(2):209-20. PubMed ID: 21275446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
    Bilo G; Koch W; Hoshide S; Parati G
    Hypertens Res; 2014 Sep; 37(9):836-44. PubMed ID: 24942766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M; Miele C; Haag U
    Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
    Ram CV
    Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):9-19. PubMed ID: 21166525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients.
    Schmieder RE; Böhm M
    J Hum Hypertens; 2011 Jun; 25(6):354-63. PubMed ID: 20686499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).
    Bramlage P; Zemmrich C; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Lüders S
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):41-6. PubMed ID: 24410942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR; Shojaee A; Maa JF
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
    Zemmrich C; Lüders S; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Bramlage P
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):815-9. PubMed ID: 24102831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Inflammation; 2014 Feb; 37(1):154-62. PubMed ID: 24018781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
    Ram CV; Sachson R; Littlejohn T; Qian C; Shojaee A; Stoakes KA; Neutel JM
    Am J Cardiol; 2011 May; 107(9):1346-52. PubMed ID: 21497211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
    McInnes GT
    J Hum Hypertens; 2011 Jun; 25(6):343-5. PubMed ID: 21390054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.